Background. Application of gene therapy to the renal graft has a powerful potential to improve the outcome of kidney transplantation and eliminate detrimental side-effects associated with systemic therapy, through local expression of immunoregulatory or other protective molecules. However, the search for the optimal vector is still ongoing. In this study we used a modified adenovirus that has an RGD motif inserted in the HI loop of the fiber knob, as a successful strategy to transduce the renal graft. Methods. Donor Lewis rat kidneys were infused via the renal artery with solution containing either a fiber-modified adenovirus (AdTL-RGD) or an unmodified adenovirus (AdTL), or with saline. Syngeneic recipients were sacrificed after 3, 7 or 14 days. Efficiency, selectivity, localization, time course of gene expression and side-effects were studied using biochemical and immunohistological techniques. Results. Enhanced gene expression was achieved selectively in the transplanted kidney by AdTL-RGD, when compared to AdTL. Transgene expression lasted for at least 2 weeks. With the AdTL-RGD vector, the transgene was abundantly expressed in the renal interstitial fibroblasts. An increase in the number of cytotoxic T lymphocytes accompanied the use of either vector, when compared to saline. Conclusion. These data convincingly show enhanced and selective gene transfer to the fibroblasts of transplanted kidneys using an RGD-modified adenovirus, providing a highly efficient vector system for future therapeutic interventions.
Introduction
In humans, the ultimate survival of transplanted kidneys largely depends on extensive immunosuppression. Despite the development of various novel immunosuppressive drugs 1 , side effects associated with systemic immunosuppression, such as opportunistic infections and malignancies, are still major drawbacks in renal transplantation. As a consequence, these life-threatening side effects have to be balanced with effectiveness of the immunosupression regimens. A promising new strategy to overcome these problems is induction of local immunosuppression in the donor organ by the means of gene therapy. In addition, gene therapy approaches could also be used to suppress other serious transplantation-related pathological processes, such as ischemia-reperfusion injury and fibrosis.
The transplanted kidney is a particularly appropriate candidate for gene therapy, because of its accessibility. However, the lack of a highly efficient, selective and non-toxic vector system has hampered the development of a clinically applicable therapeutic strategy preventing renal transplant failure. Among the non-viral and viral vector systems currently available [reviewed in ref. 2] , adenovirus has a privileged place, mostly because of its potential to transfect a broad panel of cells, including both dividing and non-dividing cells. Moreover, when used in the transplantation setting, adenovirus has the additional advantage that it can infect several cell types at low temperature, allowing pretransplantation gene transfer to be carried out during the period of cold preservation 3 . Adenovirus targets cells via binding of the fiber knob to the Coxsackie adenovirus receptor (CAR). After binding, internalization is achieved through an interaction between an Arg-Gly-Asp (RGD) motif present in the penton base of the virus and cell surface integrins (mainly αv-type). CAR expression is scarce in human kidneys 4 . Moreover, even in species in which CAR is abundantly expressed in the kidney, such as mouse or rat 4 , efficiency of renal transduction remains low. Recently, a number of strategies aiming at enhancing the infectivity of adenovirus through re-targeting to CAR-independent pathways have been developed 5;6 . Amongst them, the recombinant insertion of an RGD motif into the fiber knob 7 , leading to binding of the virus to integrins, is particularly attractive for the setting of kidney transplantation, since integrins are widely expressed within the kidney 8 . Besides the Cterminal end of the knob, which was initially selected for insertion, the HI loop has emerged as a more suitable site for genetic modification. This region is exposed on the exterior of the fiber knob, being accessible for binding to cellular targets. Moreover, the HI loop allows for insertion of relatively large sequences without affecting the structural integrity of the knob trimer 9 . Enhanced infectivity can thus be achieved since both CAR-dependent and CARindependent cell entry pathways can be employed.
In this study we used a modified adenovirus that has a RGD motif inserted in the HI loop of the fiber knob, as a successful strategy to enhance efficiency of adenovirus-mediated gene delivery to the transplanted kidney. The specific targeting of the interstitium, as achieved in our study, is of particular relevance for transplanted kidneys, in which the interstitium is the theatre of both rejection and fibrosis.
Methods

Experimental model
Inbred male Lewis rats (Lew SsnHsd, Harlan, UK) weighing 200-250 g were used. Animals were housed in a light-and temperature-controlled environment and fed standard rodent chow and water ad libitum. The animal experimental protocols were approved by the Animal Research Ethics Committee of the University of Groningen, The Netherlands.
Experiments were performed in a rat Lewis to Lewis kidney transplantation model. Donor rats were anaesthetised with isoflurane and the aorta and the left renal pedicle were exposed through a midline incision. The aorta was clamped between the renal pedicles and above the bifurcation and the left kidney was then perfused in situ with saline, followed by infusion of 0.4 ml of viral solution. At the time of infusion the renal vein was clamped. At the end of infusion the renal artery was also clamped and the kidney was taken out and placed in saline on ice for 20 min. The kidney was then slowly perfused with saline and transplanted orthotopically into a syngeneic animal, as previously described 10 . Briefly, in the recipient the left renal vessels and ureter were anastomosed end to end using 10-0 prolene sutures, with a warm ischemia time of 25 min. The right native kidney was left inside until the time of animal sacrifice.
Vectors
First generation recombinant adenovirus type 5 AdTL 11 and AdTL-RGD 7 were generously provided by Dr. David T. Curiel, University of Alabama at Birmingham, Birmingham, Alabama, USA. Both adenoviruses express green fluorescent protein (GFP, T) and firefly luciferase (L) under the control of a CMV promoter, in the E1 region. The viruses were isogenic, except for the presence of RGD sequence in the AdTL-RGD. Adenoviruses were propagated on 293 cells and purified by double CsCl density centrifugation. The amount of viral particles (VP) was determined spectrophotometrically at 260nm. The infectivity of the viruses was determined by plaque assay on 293 cells and expressed as plaque-forming units per millilitre of virus stock (pfu/ml). The VP/pfu ratio of the virus stocks was 100/1.
Experimental groups
In a first series of experiments the optimal titer of AdTL-RGD for transfection of the transplanted kidney was determined. Animals were randomly divided into five groups (n=5 transplanted animals/group) that received saline or 0.8×10 9 , 1.5×10 9 , 3×10 9 and 6x10 9 pfu, respectively. After 3 days, the rats were sacrificed and both kidneys, as well as the liver, brain, heart, lungs, spleen, gut and testis were removed and processed for luciferase assay, confocal microscopy and immunohistology.
In a second series of experiments the time course of reporter gene expression was studied, animals being treated with the optimal AdTL-RGD titer. Two groups of animals (n=5/group) were sacrificed at day 7 and 14 after transplantation and the same organs as mentioned above were removed and analysed for luciferase activity.
Thirdly, the suitability of AdTL-RGD-mediated gene delivery for renal transplantation was compared with that of an unmodified AdTL (n=4-5/group). For that purpose, efficiency, tissue distribution, and side-effects were studied at day 3, 7 and 14 after transplantation. Rats that received kidneys infused with saline (n=4-5/time-point) were included as controls.
Tissue processing
At the time of animal sacrifice, the whole body was perfused with saline and various organs were collected. One half organ was prepared for luciferase assay. From the other half, two slices were obtained. For confocal microscopy, one slice was fixed in 4% paraformaldehyde solution containing 50 % sucrose, as previously described 12 . After 48 h of incubation at 8°C, specimens were snap frozen in liquid nitrogen and stored at -80°C. For immunohistochemistry and immunofluorescence, the other slice was processed for paraffin embedding.
Luciferase activity assay
The luciferase activity after transfection with either AdTL-RGD or AdTL was measured using a luciferase assay kit (Luciferase Assay System, Promega Corporation, Madison, WI), according to the manufacturer's recommendations. Briefly, the tissue was homogenized at room temperature in lysis buffer, incubated on ice for 1h and then centrifuged at 4°C. For luminometry, 10 µl of supernatant was added to 50 µl luciferase assay reagent at room temperature and the emitted light was immediately measured using a Wallac Victor 2 (Turku, Finland) luminometer. Results are expressed as counts per second (CPS)/mg protein. Protein concentration of the tissue sample was determined by a Bradford protein assay, using bovine serum albumin as standard.
Confocal microscopy
Cells infected with GFP-expressing adenoviruses were visualized with an LSM 410 laser scanning microscope (Carl Zeiss, Jena, Germany) using a 40× or 63× oil immersion objective. Confocal images of GFP fluorescence were collected using 488-nm excitation light from a 2-line argon laser and a 510-525 nm band-pass filter. Simultaneously, structural information of the kidney was obtained by detection of autofluorescence at emission wavelengths higher than 570 nm using a 570nm long-pass filter. 3D information of thick tissue sections (40 to 60 μm) of paraformaldehyde-sucrose fixed tissue was obtained from a stack of optical sections. Images were obtained by projection of a stack of 30 optical sections representing 30 μm thickness.
Immunohistochemistry and immunofluorescence
To localize the transgene expression, a GFP immunostaining was performed using a rabbit polyclonal anti-GFP antibody (Molecular Probes, Leiden, the Netherlands). To identify the infected cells, additional (double) immunostainings were performed, using markers for fibroblasts (mouse anti-rat prolyl 4-hydroxylase, rPH, Acris Antibodies, Germany), activated fibroblasts (mouse monoclonal anti-α-smooth muscle actin, α-SMA, Sigma Chemical Co, St Louis, MO, USA), macrophages (mouse monoclonal anti-ED-1, Serotec Ltd, Oxford, UK), endothelial cells (mouse monoclonal anti-RECA-1, generously provided by Prof. G. Molema, UMCG, the Netherlands) and mesangial cells (mouse monoclonal antiThy-1, kind gift from Dr. W.W. Bakker, UMCG, the Netherlands). To evaluate the renal damage after the transplantation-infection procedure, sections were stained for SMA, macrophages (ED-1) and cytotoxic T lymphocytes (mouse monoclonal anti-CD8, a generous gift from Dr. J.L Hillebrand, UMCG, the Netherlands). Prior to the immunostaining procedure, paraffin sections (3 μm) were dewaxed and subjected to antigen retrieval by microwave induced heat in 0.1M Tris/HCl, pH 9.0 (GFP) or in 1mM EDTA buffer, pH 8.0 (CD8), overnight incubation in 0.1M Tris/HCl buffer, pH 9.0, at 80°C (α-SMA, ED-1) or 0.1% protease (Thy-1).
For immunohistochemistry, a 2-step immunoperoxidase technique was used, according to standard methods. In short, after blockade of endogenous peroxidase (PO), the primary antibody diluted in 1% bovine serum albumin (BSA) in phosphate buffered saline (PBS) was incubated for 1 hour at room temperature. Then the sections were incubated with POlabelled secondary antibodies (Dakopatts, Glostrupp, Denmark) for 30 min. All PO-labelled antibody dilutions were made in 1% BSA/PBS supplemented with 1% normal rat serum. Peroxidase activity was developed using 3',3'-diaminobenzidine tetrachloride (DAB) and H2O2. Control slides, in which the primary antibody was replaced with either PBS or IgG were consistently negative.
For double immunofluorescence, sections were incubated with primary antibodies (GFP and either rPH, α-SMA, ED-1 or RECA-1) in 1%BSA/PBS for 60 min at room temperature, followed by FITC-conjugated goat anti-rabbit and TRITC-conjugated goat antimouse antibodies (both from Southern Biotechnology Associates, Birmingham, Alabama, USA) in BSA/PBS supplemented with normal rat serum, for 30 min. Green (GFP) and red (rPH, SMA, ED-1 or RECA-1) fluorescent signals were visualized using confocal microscopy.
Morphometry
The number of glomeruli positive for GFP immunostaining was counted in 10 optical fields at 100× magnification. A glomerulus was considered positive if at least 3 cells showed GFP staining.
The expression of α-SMA and ED-1 by immunohistochemistry was measured using computer-assisted morphometry. Thirty (α-SMA) or 40 (ED-1) fields were evaluated at a magnification of 200×. For α-SMA, the total staining was divided by the area measured, and expressed as a percentage. For ED-1, the number of positive cells per area was measured. An average score was calculated per section. CD8 positive cells were counted in 30 fields using an ocular grid at 400× magnification and expressed as an average per field.
Statistical analysis
Results are presented as mean ± s.e.m.. Statistical analyses were performed using ANOVA and Student-Newman-Keuls test. Difference were considered significant at p<0.05.
Results
Viral titer optimization and time course of AdTL-RGD expression
Preliminary experiments showed that both AdTL-RGD and AdTL-delivered genes are optimally expressed between 48-72 hours after infection. Initially, the optimal viral titer of AdTL-RGD was sought, taking as criteria the transduction efficiency and selectivity. The highest transduction of the transplanted kidney, measured as luciferase activity at 72 hours, was found at a titer of 3×10 9 pfu (Fig. 1) . Infusion of 0.8×10 9 pfu resulted in 1.68×10 4 ± 0.58×10 4 CPS/mg protein, and 1.5×10 9 pfu yielded 1.61×10 5 ± 0.56 ×10 5 CPS/mg protein. In the 3×10 9 pfu-infused kidneys the luciferase activity was 4.91×10 5 ± 0.78×10 5 CPS/mg protein (30 times higher than with the lowest titer). When 6×10 9 pfu were used, no further improvement in transduction efficiency was achieved (4.41×10 5 ± 1.03×10 5 CPS/mg protein). The salinetreated animals were negative for luciferase activity.
Tissue distribution of AdTL-RGD, measured as luciferase activity at 72 hours in homogenates of various organs, showed a similar pattern in all the infected animals. All organs studied were devoid of luciferase, except for liver and spleen, in which very low, though dose-dependent levels of luciferase activity were detected (Fig. 1) . Since the 3×10 9 pfu yielded the highest and still graft-targeted transgene expression, this viral titer was considered as optimal and used to study the time course of the transgene expression. The transplanted kidney showed the highest luciferase activity at day 3, decreasing over time to day 14 after transplantation ( Fig. 2) . All the other organs were negative for luciferase at both day 7 and day 14 (data not shown).
Enhanced delivery of the transgene through AdTL-RGD compared to AdTL
The infection efficiency and selectivity of AdTL-RGD was compared with that of an adenovirus that lacks the RGD modification in the fiber. Seventy two hours after transplantation, AdTL yielded in the transplanted kidney less than 20% of the luciferase obtained with AdTL-RGD (Fig. 3) . Infection of the transplanted kidney with AdTL did not result in expression in all the other organs, except for liver and spleen, which exhibited very low levels of the transgene, comparable with those yielded by AdTL-RGD (data not shown). 
RGD-AdTL infects with high efficiency the fibroblasts of the transplanted kidney
To confirm the luciferase assay data and to determine the localization of AdTL-RGDdelivered genes, expression of GFP was studied using immunohistochemistry. Consistent with luciferase activity data, a viral dose-dependent amount of GFP expression was found in the transplanted-infected kidneys. In all the other organs GFP was not detectable (data not shown).
In the transplanted kidneys treated with the optimal AdTL-RGD titer (3×10 9 pfu), GFP staining was abundantly localized in interstitial cells, between the tubules, mainly in the cortex, also in the outer medulla, and to a lesser extent in the inner medulla (Fig. 4A, B) . Besides, approximately 12% of the glomeruli exhibited staining for GFP (Fig. 4C) . No GFP expression was seen in tubular epithelial cells. Saline treated kidneys were negative for GFP (Fig. 4F) . To identify the interstitial cell type, thick kidney sections were analysed using confocal microscopy. Reconstructed 3D images of the transplanted kidney clearly showed that the GFP signal was localized outside of the tubular structures, in cells morphologically resembling fibroblasts (Fig. 5A, B) . Accordingly, double immunfluorescence for GFP and rPH, a marker for fibroblasts, showed co-localization of GFP-and rPH-expressing cells (Fig.  5C) . Furthermore, many of the transduced interstitial fibroblasts were activated fibroblasts, as shown by the double staining for GFP and α-SMA (Fig. 5D) . On the contrary, neither GFP and ED-1, nor GFP and RECA-1 were co-localized (Fig. 5E, F) , ruling out the possibility that the infected cells were interstitial macrophages or interstitial endothelial cells.
In the positive glomeruli, only a limited number of cells (between 3 and 17 per glomerulus) showed staining for GFP. The majority (80-90%) of the glomerular cells expressing GFP were localized in mesangium, and proved to be mesangial cells, as shown by the co-localization of GFP and Thy-1 staining in consecutive sections (Fig. 6) .
In contrast with AdTL-RGD, and in line with luciferase data, a strongly reduced number of GFP-positive interstitial cells scattered over the kidney sections was found following infection with AdTL (Fig. 4D, E) . GFP-positive interstitial cells were identified as fibroblasts using the same approach as for AdTL-RGD. However, administration of AdTL resulted in a similar amount and localization of infected cells in glomeruli (average12.8%) as found with AdTL-RGD. 
Renal (immuno)histology after transplantation-infection
To determine whether AdTL-RGD and AdTL induced any additional injury in the transplanted kidneys, expression of α-SMA, an early marker of renal damage, as well as the presence of inflammatory cells macrophages (ED-1) and cytotoxic T lymphocytes (CD8) were evaluated 3, 7 and 14 days after the procedure and compared to saline treated transplants. The results are summarized in Table 1 . No difference in the expression of either interstitial α-SMA or interstitial ED1 (macrophages) was found between the saline and Interstitial cytotoxic T lymphocytes (CD8+ cells) day 3 day 7 day 14
9.5 ± 0.9 14.1 ± 0.5 11.0 ± 0.8 11.9 ± 0.5 * 25.1 ± 0.7 * 17.8 ± 1.2 * 12.4 ± 0.7 * 23.4 ± 1.3 * 15.1 ± 0.6 * AdTL-or AdTL-RGD-infused kidneys at any time point. However, an increase in interstitial CD8+ (cytotoxic T) cells was detected in the transplanted kidneys of the virus-treated animals (p<0.05 compared to saline), irrespective of the virus modification. Infiltration with CD8+ cells reached the maximum at day 7 and decreased thereafter. No immune cell infiltration (macrophages and cytotoxic lymphocytes) was present in other organs, including the liver, in animals receiving a virus-infused kidney (data not shown). This is in line with luciferase and GFP data, showing practically absence of transgene expression in organs other than the transplanted kidney.
Discussion
The present study demonstrates highly efficient and selective gene transfer to the transplanted kidneys using an adenovirus that has an RGD motif inserted in the HI loop of the fiber knob. Employing this strategy, enhanced infectivity of the adenovirus was achieved, without increasing the virus-induced renal damage. Moreover, to our knowledge, we are the first to describe efficient transduction of the interstitial fibroblasts in the model of renal transplantation.
Previous studies emphasized superiority of adenovirus compared to other vectors available for transduction of the transplanted kidney [reviewed in ref . 2] . Depending on different parameters of graft perfusion, such as temperature, perfusion pressure and viral dose, targeting to different renal compartments was achieved. However, long incubation and rather sophisticated perfusion systems were generally required in order to achieve transgene expression in the renal graft. In this study we report a rapid and highly efficient method to transfect the transplanted kidney through a RGD-modified adenovirus. Using an intra-arterial infusion combined with clamping of the renal vein, followed by 20 min incubation at 4˚C, we were able to obtain evenly distributed transgene expression in the cortex and the outer medulla of the renal graft. However, the same amount of unmodified adenovirus yielded significantly less transgene expression, as shown by both luciferase activity as well as GFP staining. This finding is in line with previous reports, showing augmented infectivity of RGD-adenovirus both in vitro 13;14 and in organs other than the kidney, in several animal models 13;14;15 .
Importantly, transgene expression was restricted to the renal graft. Apparently, it was mainly the specific setting of transplantation (which allowed us to flush out the viral solution before transplantation) that counted for selectivity, since the same tissue distribution pattern was observed for both adenoviral vectors. The very low levels of luciferase found in liver and spleen were presumably the result of a limited amount of virus re-circulating from the donor kidney after transplantation.
The targeted cells within the renal graft were mainly interstitial fibroblasts, and a limited number of glomerular cells. Previous studies that used recombinant adenovirus to transduce renal graft showed localization of transgene in either proximal 16;17 and distal 17 tubular epithelial cells, glomeruli 18 or blood vessels 19 . The exact mechanism of targeting in each of these studies is not completely elucidated. Targeting of tubules could be a result of either glomerular filtration or passage of adenoviral particles trough the peritubular capillaries, followed by tubular infection. Glomerular transduction could be achieved by continuous and prolonged perfusion of the kidney with viral solution. Blood vessels could be infected using high pressure and prolonged incubation. Besides, species differences should also be taken into account when comparing the results of these studies. It is tempting to speculate about a mechanism of targeting in our study, as well. Most likely, during the infusion via de renal artery, the virus reaches and passes glomeruli without being filtered, as we did not see any transgene expression in the tubules. A limited amount a virus infects glomerular cells. Most of the virus reaches the interstitium, probably passing through peritubular capillaries. In the interstitium, the interaction between RGD peptide and the integrins on the surface of fibroblasts 20 is responsible for enhanced infectivity of AdTL-RGD. An alternative explanation could be that the RGD-adenovirus (and not the unmodified adenovirus) reaches the interstitium via the vasa rectae, through interaction with the integrins. However, as mostly the cortical and less the medullar area was transduced, this pathway seems less plausible, or less important. Why specifically the fibroblasts were infected in our study and not other cell types that also express integrins, such as endothelial cells, is also not entirely clear. Earlier, McDonald et al. 21 observed selective transgene expression in the renal cortical vasculature, when using a RGD insertion in the C-terminus of the fiber. Differences in infusion technique, RGD location in the virus 22 or threedimensional (circular or linear) structure of the RGD sequence 23 may well explain distinct targeting in these two studies. Interestingly, although the RGD-adenovirus infected the interstitial fibroblasts much more efficiently than the unmodified adenovirus, the percentage of infected glomeruli remained the same.Since AdTL-RGD retains the CARbinding property, it is likely that CAR expression is a limiting factor for glomerular transduction, whereas CAR-independent pathways are more important for transduction of interstitial fibroblasts. Thus, it seems conceivable that the use of a CAR-ablated, RGDmodified adenovirus would lead to specific targeting of interstitial fibroblasts. However, as the overall number of transduced glomerular cells was rather low, the use of such a truly retargeted vector does not seem to be essentially required in our experimental system.
Targeting of fibroblasts, as achieved in our study, is of general importance for designing pathophysiological and therapeutical studies regarding progressive renal diseases, where fibrosis is a common final pathway 24 . From previous studies attempting targeting of renal fibroblasts in vivo, few strategies were successful: ureteral injection of hemagglutinating virus of Japan (HVJ) liposomes 25 , injection of a large volume of naked plasmid DNA via the renal vein 26 and ureteral injection of DNA plasmids combined with electroporation 27 . However, data on fibroblast transduction in the setting of kidney transplantation is lacking. Particularly for the renal graft, targeting of interstitium is of great importance for preventing both short and long-term events, as the interstitium is the theater of both acute rejection as well as long-term fibrosis. With the first generation adenovirus that we used in this study, transgene expression is short lasting, due to the immune response elicited by the virus. However, local expression of immunosupressive molecules with this vector system might not only influence the rejection of the renal graft, but also inhibit the immune response against the virus itself, thereby prolonging the availability of the gene product 28 . Most suitable in this respect would probably be factors acting in a paracrine fashion, such as immunosuppressive cytokines, which would be able to modulate the tubulo-interstitial microenvironment during the first weeks after transplantation.
Proliferation and activation of the interstitial fibroblasts into α-SMA expressing myofibroblasts is widely recognized as a key event in early transplantation-related injury, leading to fibrosis and ultimately loss of renal graft function 29 . Thus, blockade of early activation of interstitial fibroblasts might limit long-term fibrosis. In our study, many of the infected cells were SMA-expressing fibroblasts (myofibroblasts). The SMA expression was maximal at day 3-4 and overlapped with the maximal expression of the transgene. Therefore, blockade of fibroblast activation seems feasible, through targeted expression of, for instance, TGF-blocking molecules (such as members of Smad family). If extension of expression time is required, the insertion of the RGD motif in a 3 rd generation ("gutless") adenovirus, would be more suitable, as this would allow prolonged production of the transgene 30 in the interstitial fibroblasts.
Kidney transplantation is associated with marked injury due to ischemia and reperfusion. First generation adenovirus, as used in our study, elicits both innate and adaptive immune responses and may also induce renal damage. In our study, no additional rise in either interstitial smooth muscle cell actin (SMA) expression, an early marker for renal damage, or macrophage influx was found in the virus-infused kidneys. However, an increase in cytotoxic T lymphocytes accompanied the adenoviral infection. Remarkably, enhanced transfection efficiency of AdTL-RGD did not further increase AdTL-induced immune response, as reflected by the number of CD8+ cells. It is also noteworthy that the increased number of cytotoxic lymphocytes at later time points (especially day 7) was not accompanied by an additional renal damage, as evaluated by the amount of SMA expression, at any time point.
In summary, our current data convincingly show enhanced and selective gene transfer to the interstitial fibroblasts of rat transplanted kidney with a RGD-modified adenovirus, allowing further design of local immunosuppressive strategies for prevention of acute rejection. For chronic renal transplant failure, a RGD-"gutless" adenovirus would probably be more suitable for approaching local immunosuppressive or/and anti-fibrotic therapeutic strategies.
